In covering the D.C. innovation economy comes the inevitable: funding news. Trust us, there’s a lot of it floating around the D.C. metro area. Here’s a roundup of all of the major funding news from the region in November:
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced that the Company has entered an exclusive, worldwide license agreement with MedImmune, the global biologics research and development arm of AstraZeneca, for PB2452 (formerly MEDI2452), a Phase 1-ready reversal agent for ticagrelor.
Complex tissues. Surprisingly simple.
Enabling you to study complex 3D tissue biology in a simple device, that’s our goal. With perfused vessels, co-culture and optimized microenvironments. So easy to use that you forget you’re working with a highly advanced 3D culture platform. With the OrganoPlate®, we believe we’ve reached that goal. Say hello to the future of 3D tissue models.
What makes the body of a person or any other organism work can for the most part be summed up in a word: proteins.
These big molecules carry out almost all processes in living organisms, including moving other molecules from one place to another, replicating DNA, conveying genetic information from genes to cells, controlling immune response, driving metabolism and building muscle. Not all protein molecules are created equal, though, and some are better understood than others.
A medical device developer has created a $10-million venture capital fund to support early stage health care companies.
Holland-based Genesis Innovation Group said today it established the privately funded cultivate(MD) Capital Fund I, LLC, which will focus on medical device and orthopedic technologies.
Avantor, Inc., a global supplier of ultra-high-purity materials for the life sciences and advanced technology industries, today announced the successful completion of its acquisition of VWR Corporation (NASDAQ: VWR), the leading global independent provider of product, supply chain, and service solutions to laboratory and production customers. VWR will operate as a wholly-owned subsidiary of Avantor. Michael Stubblefield, Chief Executive Officer of Avantor, will lead the combined company.
The American Angel, a new comprehensive national study released today, provides a detailed picture of angel investors, who they are, where they live, and how they make investment decisions. Key findings include:
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the HyperCap Target Enrichment Portfolio, a streamlined and fully integrated NGS sample preparation. HyperCap integrates KAPA DNA Library Prep with SeqCap EZ target enrichment portfolio, and is a further expansion of the HyperCap v1.0 workflow.
Are you seeking lab space in Maryland? Limited incubator and small (1,200-3,400) lab space is available directly and through subleases in various locations from Montgomery County to Hagerstown, Frederick to Baltimore. For more information regarding this space, contact BHI@BioHealthInnovation.org.
Rita Colwell, a Distinguished University Professor in the University of Maryland Institute for Advanced Computer Studies (UMIACS), has been awarded the rank of Chevalier (Knight) in the Legion of Honor by decree of the President of the French Republic. Colwell was presented the Insignia of Chevalier de la Légion d’Honneur by Gérard Araud, Ambassador of France to the United States, in a ceremony on November 20 at the ambassador’s residence in Washington, D.C.